Functional polymorphisms of the TET1 gene increase the risk of neuroblastoma in Chinese children

Abstract

Common genetic mutations are absent in neuroblastoma, one of the most common childhood tumours. As a demethylase of 5‐methylcytosine (m5C) modification, TET1 plays an important role in tumourigenesis and differentiation. However, the association between TET1 gene polymorphisms and susceptibility to neuroblastoma has not been reported. Three TET1 gene polymorphisms (rs16925541 A > G, rs3998860 G > A and rs12781492 A > C) in 402 Chinese patients with neuroblastoma and 473 cancer‐free controls were assessed using TaqMan. Multivariate logistic regression analysis was used to evaluate the association between TET1 gene polymorphisms and susceptibility to neuroblastoma. The GTEx database was used to analyse the impact of these polymorphisms on peripheral gene expression. The relationship between gene expression and prognosis was analysed using Kaplan–Meier analysis with the R2 platform. We found that both rs3998860 G > A and rs12781492 A > C were significantly associated with increased neuroblastoma risk. Stratified analysis further showed that rs3998860 G > A and rs12781492 A > C significantly increased neuroblastoma risk in certain subgroups. In the combined risk genotype model, 1–3 risk genotypes significantly increased risk of neuroblastoma compared with the 0 risk genotype. rs3998860 G > A and rs12781492 A > C were significantly associated with increased STOX1 mRNA expression in adrenal and whole blood, and high expression of STOX1 mRNA in adrenal and whole blood was significantly associated with worse prognosis. In summary, TET1 gene polymorphisms are significantly associated with increased neuroblastoma risk; further research is required for the potential mechanism and therapeutic prospects in neuroblastoma.

TET3 gene rs828867 G>A polymorphism reduces neuroblastoma risk in Chinese children

“…: 202112141-1). In total, 402 neuroblastoma patients and 473 control volunteers were registered in the Children's Hospital of Nanjing Medical University in Jiangsu Province, China [ 33 ]. All patients consented to participate in this research and signed informed consent.…”

Genetic variants of m7G modification genes influence neuroblastoma susceptibility

“…This case-control study involved a total of 402 histopathologically and clinically diagnosed neuroblastoma cases and 473 cancer-free controls [ 30 , 31 ]. All the subjects were recruited from the Jiangsu province of Eastern China.…”